Treatment strategies for focal epilepsy

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 5, 2009, Pages 743-753

  Bauer, Jürgen ^a,b   Bös, Monika ^c   Reuber, Markus ^d  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c St Johannes Hospital Troisdorf   (Germany)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antiepileptic drugs; Epilepsy surgery; Focal epilepsy; Monotherapy; Pharmacotherapy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PRIMIDONE; RUFINAMIDE; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADD ON THERAPY; ANOVULATION; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONGENITAL MALFORMATION; DEPRESSION; DISEASE ASSOCIATION; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOCRINE DISEASE; FOCAL EPILEPSY; GENITAL SYSTEM DISEASE; HUMAN; MONOTHERAPY; MOOD DISORDER; REVIEW; RISK FACTOR; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; TERATOGENESIS; TESTOSTERONE BLOOD LEVEL; TONIC CLONIC SEIZURE; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; WEIGHT GAIN;

ANIMALS; ANTICONVULSANTS; DISEASE MANAGEMENT; EPILEPSIES, PARTIAL; HUMANS; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 64249110276     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902772328     Document Type: Review

References (73)

1. Bauer J, Buchmüller L, Reuber M, Burr W. Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy. Acta Neurol Scand 2008;117:55-59 (Pubitemid 350264506)
2. Sillanpää M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain 2008;131:938-944
3. Wiebe S, Blume WT, Girvin JP, Eliasziw M. Effectiveness and efficiency of surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-318 • This study proved the superiority of epilepsy surgery compared with anticonvulsant comedication in patients with previously intractable seizures.
4. Marson AG, Al-Kharusi AM, Alwaidh M, et al. On behalf of the SANAD Study Group. Carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for partial epilepsy: results from the SANAD trial. Lancet 2007;369:1000-1015 •• Major study on epilepsy treatment with anticonvulsant monotherapy. The study proved various AEDs to be of similar anticonvulsant efficacy.
5. Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002;58(Suppl 5):S2-S8 • Summary of treatment schedules for medical treatment of epilepsy. (Pubitemid 34415365)
6. Seconds European Working Group on Epilepsy. Epilepsy and driving. 3 April 2005 (handout of final report)
7. Dulac O, Leppik IE, Chadwick DW, Specchio LM. Starting and stopping treatment. Second edition. In: Engel J Jr, Pedley TA editors, Epilepsy: a comprehensive textbook. Philadelphia: Wolter Kluwer/Lippincott Williams & Williams 2008;3101-11309
8. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005;365:2007-2013 (Pubitemid 40805008)
9. Gilad R, Lampl Y, Gabbay U, et al. Early treatment of single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol 1996;53:1149-1152 (Pubitemid 26380297)
10. First Seizure Trial Group. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 1993;43:478-483 (Pubitemid 23088477)
11. Mattson RH, Cramer JA, Collins JF. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151 (Pubitemid 15047456)
12. Beghi E, Berg AT, Shinnar S, Hauser WA. Treatment of single and infrequent seizures. Second edition. In: Engel J Jr, Pedley TA, editors, Epilepsy: a comprehensive textbook. Wolters Kluwer/Lippincott Williams & Wilkins; 2008:1327-1333
13. Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 1997;49:991-998 (Pubitemid 27456076)
14. Camfield P, Camfield C, Smith S, et al. Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood. Epilepsia 2002;43:662-663 (Pubitemid 34627728)
15. Harden CL. Antiepileptic drug teratogenensis. What are the risks for congenital malformations and adverse cognitive outcomes? Int Rev Neurobiol 2008;83:206-213
16. Rowan AJ, Ramsay RE, Collins JF and the VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005;64:1868-1873.
17. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-87 (Pubitemid 29413167)
18. Pugh MJ, van Cott AC, Cramer JA, et al. Trends in antiepileptic drugs prescribing for older patients with new-onset epilepsy: 2000-2004. Neurology 2008;70:2171-2178
19. Stephen LJ, Brodie MJ. Seizure freedom with more than one antiepileptic drug. Seizure 2002;11:349-351 (Pubitemid 35154146)
20. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-381 (Pubitemid 350105951)
21. Gazzola DM, Balcer LJ, French JA. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 2007;48:1303-1307 • This study highlights the chance of antiepileptic comedication to achieve complete seizure control in patients with chronic epilepsy. (Pubitemid 47063094)
22. Bauer J, Ben-Menachem E, Krämer G, et al. Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 2006;114:169-176 (Pubitemid 44185909)
23. Wellmer S, Wellmer J, Bauer J. Zonisamide as add-on treatment of focal epilepsies. An outcome analysis in 74 patients (in German). Nervenarzt 2008. [Epub ahead of print]
24. Faught E, Ayala R, Montouris GG, Leppik IE. Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-1779
25. Brodie MJ, Duncan R, Vespignani H, et al. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures. Epilepsia 2005;46:31-41 (Pubitemid 40179930)
26. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67-73 (Pubitemid 23152402)
27. Sackellares JC, Ramsay RE, Wilder BJ, et al. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 2004;45:610-617 (Pubitemid 38802207)
28. Beerlage S, Bauer J. Epilepsy treatment with topiramate. A 12- and 24-months treatment analysis in 98 patients (in German). Akt Neurol 2007;34:555-558
29. Chahem J, Bauer J. Treatment of epilepsy with third-line antiepileptic drugs: felbamate, tiagabine and sulthiame (in German). Nervenarzt 2007;78:1407-1412 (Pubitemid 350196841)
30. Krakow K, Lengler U, Rettig K, et al. Topiramate in add-on therapy: results from an open-label, observational study. Seizure 2007;16:593-600 (Pubitemid 47307250)
31. Chung S, Wang N, Hank N. Comparative retention rates and long-term tolerability of new antiepileptic drugs. Seizure 2007;16:296-304 (Pubitemid 46614649)
32. Bauer J, Ruocco A. Epilepsy therapy with pregabalin. Treatment follow-up in 103 patients (in German). Aktuel Neurol 2006;33:439-441
33. Peltola J, Peltola M, Auvinen A, et al. Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study. Acta Neurol Scand 2009;119:55-60
34. Loszadi D, Hemming K, Marson AG. Pregabalin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2008;23(1):CD005612 (Pubitemid 351807664)
35. Michael B, Marson AG. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev 2008;16(2): CD004154 (Pubitemid 351807252)
36. De Herdt V, Boon P, Ceulemans B, et al. Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol 2007;11:261-269 (Pubitemid 47207780)
37. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198 •• Study on number and type of malformations caused by anticonvulsant treatment during pregnancy. A major result is the dose-depending number of malformations in children exposed to lamotrigine in utero. (Pubitemid 43220841)
38. Cunnington M, Ferber S, Quartey G, et al. Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an International Observational Study. Epilepsia 2007;48:1207-1210 (Pubitemid 46854869)
39. Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701 (Pubitemid 40695290)
40. Holmes LB, Wyszynski DF, Liebermann E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 2004;61:673-678 (Pubitemid 38637683)
41. Schramm J, Ral T, Grunwald T, Blümcke I. Surgical treatment for neocortical temporal lobe epilepsy: clinical and surgical aspects and seizure outcome. J Neurosurg 2001;94:33-42 (Pubitemid 32799469)
42. Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry 1995;58:666-673
43. Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy. Neurosurgery 1997;41:378-386 (Pubitemid 27327500)
44. Zentner J, Hufnagel A, Ostertun B, et al. Surgical treatment of extratemporal epilepsy: clinical, radiological, and histopathological findings in 60 patients. Epilepsia 1996;37:1072-1080 (Pubitemid 26391238)
45. Li LM, Cendes F, Andermann F, et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999;122:799-805 (Pubitemid 29219255)
46. Bauer J, Reuber M. Medical treatment of epilepsy. Expert Opin Emerg Drugs 2003;8:457-467 (Pubitemid 37522660)
47. Bauer J. Treatment of epilepsy in adults. Options and strategies (in German). Nervenarzt 2007;78(Suppl 1):27-35
48. Bauer J, Neumann M. Therapeutic management following diagnosis of epilepsy (in German). Fortschr Neurol Psychiat 2008;76:679-692
49. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmakokin 2000;38:191-204
50. Bauer J, Hermann A, Reuber M. Tolerability of high dosage carbamazepine monotherapy in treatment of epilepsy (in German). Nervenarzt 2002;73:533-537 (Pubitemid 36068359)
51. Perucca E. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996;42:531-543 (Pubitemid 26385257)
52. Pack AL, Walczak TS. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol 2008;83:306-328
53. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54:425-432 (Pubitemid 37176535)
54. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-222 (Pubitemid 32108114)
55. Herzog AG. Disorders of reproduction and fertility. In: Engel J. Jr. and Pedley T.A., editors. Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia 1997;2013-2026
56. Bauer J, Cooper-Mahkorn D. Reproductive dysfunction in women with epilepsy: menstrual cycle abnormalities, fertility, and polycystic ovary syndrome. Int Rev Neurobiol 2008;83:136-155
57. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-1973 (Pubitemid 29000863)
58. Meo R, Bilo L. Polycystic ovary syndrome and epilepsy. A review of the evidence. Drugs 2003;63:1185-1227 • Major review on endocrine consequences of anticonvulsant treatment in women with epilepsy.
59. Knochenhauser ES, Key TJ, Kashar-Miller M, et al. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082 (Pubitemid 28500937)
60. Bauer J, Isojärvi JIT, Herzog AG, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121-125 • Conclusions from a workshop on endocrine consequences of epilepsy and antiepileptic treatment in women. The paper summarizes clinically relevant aspects for diagnosis and treatment of endocrine disorders in these patients. (Pubitemid 41652889)
61. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 2003;44(Suppl 4):11-20 (Pubitemid 36842172)
62. Bauer J, Blumenthal S, Reuber M, Stoffel-Wagner B. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004;27:243-246 • This study highlights the impact of focal epilepsy on sexual steroid hormones in men. (Pubitemid 38167132)
63. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids of both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68 (Pubitemid 13245381)
64. Herzog AG. Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 1991;37(Suppl 6):S34-S37
65. Isojärvi JIT, TaubØll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 2005;19:207-223 • Major review on endocrine effects of AEDs on sexual steroid hormones in men. (Pubitemid 40460661)
66. Isojärvi JIT, Pakarinen AJ, Rautio A, et al. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Eur J Clin Pharmacol 1995;47:461-464
67. Patsalos PN, Zakrewska JM, Elyas AA. Dose dependent enzyme induction by oxcarbazepine. Eur J Clin Pharmacol 1990;39:187-188 (Pubitemid 20249996)
68. Rättyä J, Pakarinen AJ, Repo M, et al. Early hormonal changes during valproate or carbamazepine treatment - a 3 months study. Neurology 2001;57:440-441 (Pubitemid 32757590)
69. Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 2005;65:1016-1020 • This study proved lamotrigine to have no negative impact on male sexual functions. (Pubitemid 41429624)
70. Isojärvi JIT, Löfgren E, Juntunen KST, et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004;62:247-253 (Pubitemid 38167133)
71. Bauer J, Klingmüller D. Which antiepileptic drug for men with epilepsy? (in German). Nervenarzt 2008;79:1407-1415
72. Kühn KU, Quednow BB, Thiel M, et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003;4:674-679 (Pubitemid 38035690)
73. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006;5:399-405